{
  "id": 9241,
  "url": "https://doi.org/10.1186/s13045-022-01310-7",
  "title": "Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy",
  "summary": "Vascular endothelial growth factor receptors (VEGFRs) are a family of receptor protein tyrosine kinases that play an important role in the regulation of tumor-induced angiogenesis. Currently, VEGFR inhibitors have been widely used in the treatment of various tumors. However, current VEGFR inhibitors are limited to a certain extent due to limited clinical efficacy and potential toxicity, which hinder their clinical application. Thus, the development of new strategies to improve the clinical outco",
  "authors": "Yun Liu, Yang Li, Yuxi Wang, Congcong Lin, Dan Zhang, Juncheng Chen",
  "category": "research",
  "topics": "regulation,healthcare,biotech",
  "orgs": null,
  "regions": null,
  "published_at": "2022-07-07T00:00:00.000Z",
  "fetched_at": "2026-07-14T16:33:50.751Z",
  "source_slug": "openalex",
  "source_name": "OpenAlex",
  "source_homepage": "https://openalex.org",
  "ethics_ai_record_url": "https://ethics.ai/record/9241",
  "original_url": "https://doi.org/10.1186/s13045-022-01310-7",
  "evidence_status": "source-only",
  "attribution": "via ethics.ai"
}